Cardiac Pacemaker
10
6
7
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
10.0%
1 terminated out of 10 trials
50.0%
-36.5% vs benchmark
20%
2 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (10)
The Leadless AV Versus DDD Pacing Study
LEAP 2 Chronic EFS
Studying Routine Patient Care With BIOTRONIK Devices That Allow a More Natural Heart Stimulation
Aveir VR Coverage With Evidence Development Post-Approval Study
AVEIR Remote Care System Non-Significant Risk Study
AVEIR DR Coverage With Evidence Development (CED) Study
Aveir AR Coverage With Evidence Development (CED) Study
Aveir DR Real-World Evidence Post-Approval Study
Aveir VR Real-World Evidence Post-Approval Study
Cardiac MRI After Pacemaker Replacement